These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 21696628

  • 21. Knockdown of bone morphogenetic protein type II receptor leads to decreased aquaporin 1 expression and function in human pulmonary microvascular endothelial cells.
    Vassiliou AG, Keskinidou C, Kotanidou A, Frantzeskaki F, Dimopoulou I, Langleben D, Orfanos SE.
    Can J Physiol Pharmacol; 2020 Nov; 98(11):834-839. PubMed ID: 32687728
    [Abstract] [Full Text] [Related]

  • 22. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle.
    Hagen M, Fagan K, Steudel W, Carr M, Lane K, Rodman DM, West J.
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1473-9. PubMed ID: 17322283
    [Abstract] [Full Text] [Related]

  • 23. Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH.
    Tada Y, Majka S, Carr M, Harral J, Crona D, Kuriyama T, West J.
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1556-63. PubMed ID: 17369292
    [Abstract] [Full Text] [Related]

  • 24. In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug.
    Hopper RK, Moonen JR, Diebold I, Cao A, Rhodes CJ, Tojais NF, Hennigs JK, Gu M, Wang L, Rabinovitch M.
    Circulation; 2016 May 03; 133(18):1783-94. PubMed ID: 27045138
    [Abstract] [Full Text] [Related]

  • 25. Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice.
    Mushaben EM, Hershey GK, Pauciulo MW, Nichols WC, Le Cras TD.
    PLoS One; 2012 May 03; 7(3):e32468. PubMed ID: 22427841
    [Abstract] [Full Text] [Related]

  • 26. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC, van Zuijen I, Huang CJ, Szulcek R, Pan X, van Dinther MA, Kurakula K, Wiesmeijer CC, Goumans MJ, Bogaard HJ, Morrell NW, Rana AA, Ten Dijke P.
    J Pathol; 2019 Nov 03; 249(3):356-367. PubMed ID: 31257577
    [Abstract] [Full Text] [Related]

  • 27. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
    Li W, Hu H.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 03; 89(4):230-4. PubMed ID: 19552837
    [Abstract] [Full Text] [Related]

  • 28. Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
    Yasuda T, Tada Y, Tanabe N, Tatsumi K, West J.
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov 03; 301(5):L667-74. PubMed ID: 21856816
    [Abstract] [Full Text] [Related]

  • 29. BMP pathway regulation of and by macrophages.
    Talati M, West J, Zaynagetdinov R, Hong CC, Han W, Blackwell T, Robinson L, Blackwell TS, Lane K.
    PLoS One; 2014 Nov 03; 9(4):e94119. PubMed ID: 24713633
    [Abstract] [Full Text] [Related]

  • 30. Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.
    Prewitt AR, Ghose S, Frump AL, Datta A, Austin ED, Kenworthy AK, de Caestecker MP.
    J Biol Chem; 2015 Jan 09; 290(2):960-71. PubMed ID: 25411245
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.
    Spiekerkoetter E, Tian X, Cai J, Hopper RK, Sudheendra D, Li CG, El-Bizri N, Sawada H, Haghighat R, Chan R, Haghighat L, de Jesus Perez V, Wang L, Reddy S, Zhao M, Bernstein D, Solow-Cordero DE, Beachy PA, Wandless TJ, Ten Dijke P, Rabinovitch M.
    J Clin Invest; 2013 Aug 09; 123(8):3600-13. PubMed ID: 23867624
    [Abstract] [Full Text] [Related]

  • 33. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
    Wang Y, Zhang XH, Wang HL.
    Can J Physiol Pharmacol; 2011 May 09; 89(5):345-54. PubMed ID: 21619414
    [Abstract] [Full Text] [Related]

  • 34. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
    Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, Karoubi G, Courtman DW, Zucco L, Granton J, Stewart DJ.
    Circ Res; 2006 Feb 03; 98(2):209-17. PubMed ID: 16357305
    [Abstract] [Full Text] [Related]

  • 35. Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes.
    Miyagawa K, Shi M, Chen PI, Hennigs JK, Zhao Z, Wang M, Li CG, Saito T, Taylor S, Sa S, Cao A, Wang L, Snyder MP, Rabinovitch M.
    Circ Res; 2019 Jan 18; 124(2):211-224. PubMed ID: 30582451
    [Abstract] [Full Text] [Related]

  • 36. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M, Gomez-Puerto MC, Ten Dijke P.
    Cell Mol Life Sci; 2017 Aug 18; 74(16):2979-2995. PubMed ID: 28447104
    [Abstract] [Full Text] [Related]

  • 37. Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling.
    Theilmann AL, Hawke LG, Hilton LR, Whitford MKM, Cole DV, Mackeil JL, Dunham-Snary KJ, Mewburn J, James PD, Maurice DH, Archer SL, Ormiston ML.
    Arterioscler Thromb Vasc Biol; 2020 Nov 18; 40(11):2605-2618. PubMed ID: 32998516
    [Abstract] [Full Text] [Related]

  • 38. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function.
    Leyton PA, Beppu H, Pappas A, Martyn TM, Derwall M, Baron DM, Galdos R, Bloch DB, Bloch KD.
    PLoS One; 2013 Nov 18; 8(10):e76947. PubMed ID: 24116187
    [Abstract] [Full Text] [Related]

  • 39. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
    Li M, Vattulainen S, Aho J, Orcholski M, Rojas V, Yuan K, Helenius M, Taimen P, Myllykangas S, De Jesus Perez V, Koskenvuo JW, Alastalo TP.
    Am J Respir Cell Mol Biol; 2014 Jun 18; 50(6):1118-28. PubMed ID: 24433082
    [Abstract] [Full Text] [Related]

  • 40. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.
    Hennigs JK, Cao A, Li CG, Shi M, Mienert J, Miyagawa K, Körbelin J, Marciano DP, Chen PI, Roughley M, Elliott MV, Harper RL, Bill MA, Chappell J, Moonen JR, Diebold I, Wang L, Snyder MP, Rabinovitch M.
    Circ Res; 2021 Feb 05; 128(3):401-418. PubMed ID: 33322916
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.